WallStreetZenWallStreetZen

NASDAQ: CDMO
Avid Bioservices Inc Stock Forecast, Predictions & Price Target

Analyst price target for CDMO

Based on 2 analysts offering 12 month price targets for Avid Bioservices Inc.
Min Forecast
$20.00+23.53%
Avg Forecast
$24.00+48.24%
Max Forecast
$28.00+72.95%

Should I buy or sell CDMO stock?

Based on 2 analysts offering ratings for Avid Bioservices Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDMO stock forecasts and price targets.

CDMO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
RBC Capital
Top 16%
85
BuyMaintains$20.00+23.53%2022-12-07
Stephens & Co.
Bottom 26%
26
Strong BuyMaintains$28.00+72.95%2022-03-09

1 of 1

Forecast return on equity

Is CDMO forecast to generate an efficient return?
Company
24.07%
Industry
10.68%
Market
57.51%
CDMO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDMO forecast to generate an efficient return on assets?
Company
9.87%
Industry
12.32%
CDMO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDMO earnings per share forecast

What is CDMO's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$0.06-96.89%
Avg 2 year Forecast
$0.30-84.46%
Avg 3 year Forecast
$0.70-63.73%
CDMO's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CDMO revenue forecast

What is CDMO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$140.0M+4.34%
Avg 2 year Forecast
$190.0M+41.6%
Avg 3 year Forecast
$260.0M+93.77%
CDMO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDMO earnings growth forecast

How is CDMO forecast to perform vs Biotechnology companies and vs the US market?
Company
-57.68%
Industry
8.5%
Market
27.21%
CDMO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CDMO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CDMO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CDMO revenue growth forecast

How is CDMO forecast to perform vs Biotechnology companies and vs the US market?
Company
21.06%
Industry
64.15%
Market
11.03%
CDMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDMO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDMO$16.19$24.00+48.24%Strong Buy
ARQT$16.67$49.00+193.94%Strong Buy
BLU$8.11$20.67+154.83%Strong Buy
IGMS$24.00$35.86+49.40%Buy
RGNX$23.75$43.67+83.86%Strong Buy

Avid Bioservices Stock Forecast FAQ

Is Avid Bioservices Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDMO) stock is to Strong Buy CDMO stock.

Out of 2 analysts, 1 (50%) are recommending CDMO as a Strong Buy, 1 (50%) are recommending CDMO as a Buy, 0 (0%) are recommending CDMO as a Hold, 0 (0%) are recommending CDMO as a Sell, and 0 (0%) are recommending CDMO as a Strong Sell.

If you're new to stock investing, here's how to buy Avid Bioservices stock.

What is CDMO's earnings growth forecast for 2023-2025?

(NASDAQ: CDMO) Avid Bioservices's forecast annual earnings growth rate of -57.68% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 27.21%.

Avid Bioservices's earnings in 2023 is $118,254,000.On average, 2 Wall Street analysts forecast CDMO's earnings for 2023 to be $3,738,562, with the lowest CDMO earnings forecast at $3,115,468, and the highest CDMO earnings forecast at $4,984,749. On average, 2 Wall Street analysts forecast CDMO's earnings for 2024 to be $18,692,809, with the lowest CDMO earnings forecast at $16,823,528, and the highest CDMO earnings forecast at $19,938,996.

In 2025, CDMO is forecast to generate $43,616,554 in earnings, with the lowest earnings forecast at $43,616,554 and the highest earnings forecast at $43,616,554.

What is CDMO's revenue growth forecast for 2023-2025?

(NASDAQ: CDMO) Avid Bioservices's forecast annual revenue growth rate of 21.06% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.15%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.03%.

Avid Bioservices's revenue in 2023 is $134,183,000.On average, 1 Wall Street analysts forecast CDMO's revenue for 2023 to be $8,723,310,820, with the lowest CDMO revenue forecast at $8,723,310,820, and the highest CDMO revenue forecast at $8,723,310,820. On average, 1 Wall Street analysts forecast CDMO's revenue for 2024 to be $11,838,778,970, with the lowest CDMO revenue forecast at $11,838,778,970, and the highest CDMO revenue forecast at $11,838,778,970.

In 2025, CDMO is forecast to generate $16,200,434,380 in revenue, with the lowest revenue forecast at $16,200,434,380 and the highest revenue forecast at $16,200,434,380.

What is CDMO's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: CDMO) forecast ROA is 9.87%, which is lower than the forecast US Biotechnology industry average of 12.32%.

What is CDMO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDMO price target, the average CDMO price target is $24.00, with the highest CDMO stock price forecast at $28.00 and the lowest CDMO stock price forecast at $20.00.

On average, Wall Street analysts predict that Avid Bioservices's share price could reach $24.00 by Dec 7, 2023. The average Avid Bioservices stock price prediction forecasts a potential upside of 48.24% from the current CDMO share price of $16.19.

What is CDMO's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: CDMO) Avid Bioservices's current Earnings Per Share (EPS) is $1.93. On average, analysts forecast that CDMO's EPS will be $0.06 for 2023, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.08. On average, analysts forecast that CDMO's EPS will be $0.30 for 2024, with the lowest EPS forecast at $0.27, and the highest EPS forecast at $0.32. In 2025, CDMO's EPS is forecast to hit $0.70 (min: $0.70, max: $0.70).

What is CDMO's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: CDMO) forecast ROE is 24.07%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.